Drug development is a complex activity that requires
a broad array of medical and laboratory expertise, including toxicology,
preclinical evaluation, clinical trial design and implementation. Today's drug
development process has evolved through decades of scientific, technological
and regulatory changes - all aimed at improving the safety and efficacy of new
drugs before they come to market. As a consequence, it can take up to 12 years
or more to bring a new therapy from discovery to market - a time consuming-
capital - resource-intensive process. In face of this, many pharmaceutical,
biotech and medical device companies look to outsourcing some or all of their
drug development activities.
Through strategic outsourcing with Sristek, biopharmaceutical companies can
access additional therapeutic and regulatory expertise, extensive clinical
research experience, and state-of-the-art technology - without adding the
associated fixed costs to clients R&D overhead.
|
